windlass biotech longSmall consolidation and trend reversal with volume support.
only for information and education purpose. please consult your adviser before investing.
Key stats
Market capitalization
5.2BINR
Dividends yield (FY)
1.47%
Price to earnings Ratio (TTM)
11.40
Basic EPS (TTM)
21.10INR
About WINDLAS BIOTECH LTD
ISIN
INE0H5O01029
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
windlas.com
CEO
Komal Gupta
Headquarters
Gurgaon
Employees
962
Founded
2001
Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). It provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. The company was founded by Ashok Kumar Windlass on February 19, 2001 and is headquartered in Gurgaon, India.
good accumulation in windlas biotech.*for educational purpose only.
1)price accumulated in the narrow range.
2)forming an ascending triangle.
3)RSI is showing a good momentum with higher lows.
Windlas BiotechIt was moving downwards relatively as per Fib retracement, however today it took reversal from its bottom, but to get power it needs to close above EMA20, may see 1st target upwards around 325, in case it breakdown due to market movement may seek support on trendline from 16th aug 2021
windlass their is a strong upside potential here
as u have seen the company is really good but contious trading at discount levels
and retail invertor are not yet interested in it reight now
this is the right time to amke good entry here
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0